For a comprehensive approach to adult smoking cessation, contributions by all physicians are more relevant than individual efforts. This study is an example of a collaboration that aims to increase access to smoking cessation assistance for smokers with rheumatic diseases.

For this prospective cohort study, data were collected from adult current smokers diagnosed with inflammatory rheumatic disease. Brief cessation interventions were implemented by their primary rheumatology physician and they were informed about the smoking cessation service of the hospital. Upon their acceptance, their appointment to SCC was immediately arranged within the schedule of the clinic. After the intervention, their quit status was evaluated and confirmed by exhaled air carbon monoxide measurement at third month. Multivariate logistic regression models were used to evaluate the associated factors with successful quit status.

The mean age of the total 184 patients was 45.5 (SD=12.4) years, and 43.4% were female. The majority consisted of patients with rheumatoid arthritis (46.1%) and ankylosing spondylitis (38.0%). Of the patients, 117 (63.5%) were willing to quit. At third month, quit rate of the total group was 13.5%; 21.3% of the willing group, and 0% among the non-willing group. Among the willing group, 39% of those admitted to the cessation clinic and 14% of the non-admitters had successfully quit smoking (p<0.05). Application to the smoking cessation clinic had the highest association with successful quit attempts (OR=8.126; 95% CI: 2.488–26.536). The Fagerström test score (OR=0.672; 95% CI: 0.506–0.892) and the income level (OR=0.269; 95% CI: 0.089–0.810) were negatively associated determinants.

The highest cessation success was achieved in patients who applied to the smoking cessation outpatient clinic. Rheumatologists should build an effective bridge with smoking cessation centers for their smoker patients.

The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.
There was no source of funding for this research.
Ethical approval was obtained from the ethics committee of Recep Tayyip Erdoğan University (Approval number: 2022/174; Date: 17 October 2022). Participants provided informed consent.
The data supporting this research is available from the author(s) on reasonable request.
Not commissioned; externally peer reviewed.
Karadoğan D. Tütün ve Göğüs Hastalıkları: 1st ed. Akademisyen Kitabevi; 2020:287-289.
Karacabeyli D, Shojania K, Dehghan N, Lacaille D. Rheumatology health care providers' views and practices on obesity and smoking cessation management in rheumatoid arthritis. Clin Rheumatol. 2021;40(7):2681-2688. doi:10.1007/s10067-021-05607-9
Sugiyama D, Nishimura K, Tamaki K, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2010;69(1):70-81. doi:10.1136/ard.2008.096487
Taylor LH, Twigg S, Worthington J, et al. Metaanalysis of the association of smoking and PTPN22 R620W genotype on autoantibody status and radiological erosions in rheumatoid arthritis. J Rheumatol. 2013;40(7):1048-1053. doi:10.3899/jrheum.120784
Poddubnyy D, Haibel H, Listing J, et al. Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort (GESPIC). Ann Rheum Dis. 2013;72(8):1430-1432. doi:10.1136/annrheumdis-2012-203148
Mattey DL, Packham JC, Nixon NB, et al. Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis. Arthritis Res Ther. 2012;14(3):R127. doi:10.1186/ar3857
Bremander A, Jacobsson LT, Bergman S, Haglund E, Löfvendahl S, Petersson IF. Smoking is associated with a worse self-reported health status in patients with psoriatic arthritis: data from a Swedish population-based cohort. Clin Rheumatol. 2015;34(3):579-583. doi:10.1007/s10067-014-2742-8
Wattiaux A, Bettendorf B, Block L, et al. Patient perspectives on smoking cessation and interventions in Rheumatology Clinics. Arthritis Care Res (Hoboken). 2020;72(3):369-377. doi:10.1002/acr.23858
Naranjo A, Khan NA, Cutolo M, et al. Smoking cessation advice by rheumatologists: results of an international survey. Rheumatology (Oxford). 2014;53(10):1825-1829. doi:10.1093/rheumatology/keu213
Vreede AP, Johnson HM, Piper M, Panyard DJ, Wong JC, Bartels CM. Rheumatologists modestly more likely to counsel smokers in visits without Rheumatoid Arthritis control: an observational study. J Clin Rheumatol. 2017;23(5):273-277. doi:10.1097/RHU.0000000000000559
Bartels CM, Johnson L, Ramly E, et al. Impact of a Rheumatology Clinic Protocol on tobacco cessation quit line referrals. Arthritis Care Res (Hoboken). 2022;74(9):1421-1429. doi:10.1002/acr.24589
Çetinkaya PD, Batum Ö, Kararmaz EA, Turan A, Çetinkaya P, Çetinkaya F. Compliance with the legislation of the smoking cessation clinic in Turkey. Turk Thorac J. 2020 May;21(3):180-184. doi:10.5152/TurkThoracJ.2019.180156
Çetinkaya PD, Batum Ö, Kararmaz EA, Turan A, Çetinkaya P, Çetinkaya F. Accessibility of smoking cessation outpatient clinics in Turkey: a descriptive study among a population of smokers in Istanbul. Turkish Journal of Public Health. 2022;20(3):280–293. doi:10.20518/tjph.916741
VanFrank B, Presley-Cantrell L. A comprehensive approach to increase adult tobacco cessation. JAMA. 2021;325(3):232-233. doi:10.1001/jama.2020.23608
Kay J, Upchurch KS. ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford). 2012;51 Suppl 6:vi5-vi9. doi:10.1093/rheumatology/kes279
Rudwaleit M, van der Heijde D, Landewé R, et al. The assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70(1):25-31. doi:10.1136/ard.2010.133645
Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777-783. doi:10.1136/ard.2009.108233
Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665-2673. doi:10.1002/art.21972
Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677-2686. doi:10.1002/art.34473
Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43(2):227-253. doi:10.1016/0002-9343(67)90167-2
International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD). The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338-347. doi:10.1111/jdv.12107
Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Ann Rheum Dis. 2015;74(10):2557–2568. doi:10.1136/annrheumdis-2015-208237
Karadoğan D, Önal Ö, Kanbay Y. How does reimbursement status affect smoking cessation interventions? A real-life experience from the Eastern Black Sea region of Turkey. Tob Induc Dis. 2019;17:05. doi:10.18332/tid/100412
Karadoğan D, Önal Ö, Şahin DS, Kanbay Y, Alp S, Şahin Ü. Treatment adherence and short-term outcomes of smoking cessation outpatient clinic patients. Tob Induc Dis. 2018;16:38. doi:10.18332/tid/94212
Karadoğan D, Ardıç C, Telatar TG, et al. Towards a comprehensive tobacco-cessation approach: a pilot-training using simulation based-learning among medical students in Türkiye. Tob Induc Dis. 2023;21:118. doi:10.18332/tid/170278
Rodríguez-Bolaños R, Ponciano-Rodríguez G, Rojas-Carmona A, Cartujano-Barrera F, Arana-Chicas E, Cupertino AP, Reynales-Shigematsu LM. Practice, barriers, and facilitators of healthcare providers in smoking cessation in Mexico. Enferm Clin (Engl Ed). 2022;32(3):184-194. doi: 10.1016/j.enfcle.2021.04.004
Roelsgaard IK, Thomsen T, Østergaard M, Semb AG, Andersen L, Esbensen BA. How do people with rheumatoid arthritis experience participation in a smoking cessation trial: a qualitative study. Int J Qual Stud Health Well-being. 2020;15(1):1725997. doi:10.1080/17482631.2020.1725997
Gath ME, Stamp LK, Aimer P, Stebbings S, Treharne GJ. Reconceptualizing motivation for smoking cessation among people with rheumatoid arthritis as incentives and facilitators. Musculoskeletal Care. 2018;16(1):139-146. doi:10.1002/msc.1227
Naranjo A, Bilbao A, Erausquin C, et al. Results of a specific smoking cessation program for patients with arthritis in a rheumatology clinic. Rheumatol Int. 2014;34(1):93-99. doi:10.1007/s00296-013-2851-8
Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008;35(2):158-176. doi:10.1016/j.amepre.2008.04.009
Rigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J. Treatment of tobacco smoking: a review. JAMA. 2022;327(6):566-577. doi:10.1001/jama.2022.0395
Journals System - logo
Scroll to top